Thomas J. George

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Support of academic non-clinical efforts for cancer investigator faculty at Association of American Cancer Institutes.

  Journal of Clinical Oncology · 2026-05-28

• Activity of NP-G2-044 (fascin inhibitor) + anti–PD-1 in ICI-resistant advanced/metastatic solid tumors with expansion in cutaneous squamous cell carcinoma (CSCC).

  Journal of Clinical Oncology · 2026-05-28

• Risk of immune-related adverse events from checkpoint inhibitors in cancer patients with autoimmune disease: An emulated target trial.

  Journal of Clinical Oncology · 2026-05-27

• Glucagon-like peptide-1 receptor agonist (GLP-1 RA) and hematologic cancer risk among older adults with type 2 diabetes.

  Journal of Clinical Oncology · 2026-05-27

• Temsirolimus in Patients With Solid Tumors With <i>PIK3CA</i> Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

  JCO Precision Oncology · 2026-04-01

• Neoadjuvant Therapy for Localized Pancreatic Cancer

  Cancers · 2026-03-20

• <i>PARP1</i> and <i>BRCA1/2</i> expression and overall survival in high risk of recurrence localized clear cell-type renal cell carcinoma.

  Journal of Clinical Oncology · 2026-03-01

• Breast cancer screening and cancer prognosis in patients with Alzheimer disease and related dementias

  JNCI Cancer Spectrum · 2026-02-18

• A phase 1b study to evaluate the safety, tolerability and preliminary efficacy of a heterologous prime boost vaccination (ATP150/ATP152/ATP162, VSV-GP154) and ezabenlimab (BI 754091) in patients with pancreatic ductal adenocarcinoma.

  Journal of Clinical Oncology · 2026-01-10

• Automated Market Making with Continuity: Liquidity, Price Discovery, and Adverse SelectionPreprint

  SSRN Electronic Journal · 2026-01-01

• Do LLMs Care How You Ask? Prompt Tones and AI Accuracy, Trust, and Engagement

  Journal of the Association for Information Systems · 2025-12-14

• Severe toxicity following genotype-guided reduced 5-FU dose in a heterozygous DPYD c.2846A&gt;T carrier with stage III anal carcinoma: A case report

  Cancer Chemotherapy and Pharmacology · 2025-11-21 · 1 citations

• Impact of <i>RAS</i> / <i>BRAF</i> V600E Mutations on the Tumor Immune Microenvironment in Mismatch Repair–Deficient/Microsatellite Instability Colorectal Cancers

  Clinical Cancer Research · 2025-11-13 · 1 citations

• A real-world cohort study of immune-related adverse events in patients receiving immune checkpoint inhibitors

  npj Precision Oncology · 2025-11-11 · 13 citations

• Abstract A006: Biomarker analyses of WEE1 inhibition in patients with refractory <i>CCNE1</i> amplified solid tumors

  Molecular Cancer Therapeutics · 2025-10-22 · 1 citations

• Trends and projected burden of early-onset gastrointestinal malignancies in the United States: a population-based analysis (2001-2021)

  JNCI Journal of the National Cancer Institute · 2025-10-16 · 3 citations

• The Definition of Cure in Colon Cancer

  JAMA Oncology · 2025-10-02 · 2 citations

• Trends and characteristics of early-onset colorectal cancer in the state of Florida, 2002–2021

  Cancer Epidemiology · 2025-09-14

• The Burden of Cancer and Precancerous Conditions Among Transgender Individuals in a Large Health Care Network: Retrospective Cohort Study

  JMIR Cancer · 2025-09-08

• GLP-1 Receptor Agonists and Cancer Risk in Adults With Obesity

  JAMA Oncology · 2025-08-21 · 59 citations